WHO ICTRP trial
Dose-adjustment of enoxaparin by a bayesian pharmacological approach in…
EUCTR2021-000099-12-FR · EU Clinical Trials Register
Key facts
| Trial ID | EUCTR2021-000099-12-FR |
|---|---|
| Public title | Dose-adjustment of enoxaparin by a bayesian pharmacological approach in pediatric renal transplant recipients |
| Scientific title | Dose-adjustment of enoxaparin by a bayesian pharmacological approach in pediatric renal transplant recipients - OPTI-TREX |
| Primary sponsor | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS |
| Registry | EU Clinical Trials Register |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | Allograft vascular thrombosis MedDRA version: 20.0 Level: PT Classification code 10072226 Term: Renal vascular thrombosis System Organ Class: 10038359 - Renal and urinary disorders ;Therapeutic area: Not possible to specify |
| Interventions | Product Name: Enoxaparin Pharmaceutical Form: Solution for injection in pre-filled syringe INN or Proposed INN: ENOXAPARIN SODIUM CAS Number: 9041-08-1 Concentration unit: IU/ml international unit(s)/millilitre Concentration type: range… |
| Registration date | Sep 7, 2021 |
| Target size | 50 |
| Secondary IDs | APHP180617 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: